P2RY12 and diabetes mellitus: Moreover, a recent meta-analysis has shown that, following PCI, monotherapy with a P2Y12 inhibitor is preferable to DAPT in older individuals and those with diabetes, CKD or multivessel disease due to reduction in bleeding risk.78